| |
| Welcome to Airmid Incorporated |
| Airmid is a privately held pharmaceutical company based in Redwood City, California. Airmid is focused on developing its novel potassium ion channel blockers as safer and more effective medicines for a variety of autoimmune diseases that are inadequately treated by current therapies. These diseases include multiple sclerosis, psoriasis, diabetes, and rheumatoid arthritis. Airmid currently has two drug candidates in the preclinical phase of drug development. |
| |
|
|
 |
| July 2009 |
AIRMID partners with Kineta
to develop ShK peptides
|
| February 2009 |
Adam Bristol joins
AIRMID Board of Directors
more... |
|
